| Literature DB >> 27729744 |
Gen Tohda1, Masahiro Ohtani1, Masaki Dochin1.
Abstract
AIM: To investigate the efficacy and safety of emergency endoscopic retrograde cholangiopancreatography (ERCP) in elderly patients with acute cholangitis.Entities:
Keywords: Acute cholangitis; Comorbidity; Complication; Elderly; Endoscopic retrograde cholangiopancreatography
Mesh:
Year: 2016 PMID: 27729744 PMCID: PMC5055868 DOI: 10.3748/wjg.v22.i37.8382
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Clinical characteristics and laboratory data of enrolled patients
| Age (yr) | 85 (81-92) | 67 (58-75) | < 0.05 |
| Sex | |||
| Male | 41 (40.2) | 62 (59.0) | < 0.05 |
| Female | 61 (59.8) | 43 (41.0) | |
| Fever (centigrade) | 39.0 (38.5-39.3) | 38.9 (38.7-39.4) | NS |
| WBC (103/L) | 12.8 (10.4-15.2) | 12.5 (10.7-14.6) | NS |
| Platelet (103/L) | 132 (105-180) | 171 (130-231) | < 0.05 |
| Albumin (g/dL) | 2.9 (2.6-3.3) | 3.6 (3.4-4.0) | < 0.05 |
| Bilirubin (mg/dL) | 4.3 (3.1-6.0) | 4.2 (2.8-6.7) | NS |
| AST (U/L) | 229 (150-418) | 182 (141-256) | < 0.05 |
| ALT (U/L) | 195 (128-277) | 197 (144-303) | NS |
| ALP (U/L) | 798 (576-1154) | 811 (510-1175) | NS |
| γ-GTP (U/L) | 336 (256-451) | 350 (249-548) | NS |
| ASA | |||
| Class 2 | 34 (33.3) | 59 (56.2) | < 0.05 |
| Class 3 | 67 (65.7) | 45 (42.9) | |
| Class 4 | 1 (1.0) | 1 (1.0) |
Continuous variables are expressed as median (interquartile range; IQR), categorical variables are expressed as n (%). WBC: White blood cells; AST: Aspartate transaminase; ALT: Alanine transaminase; ALP: Alkaline phosphatase; γ-GTP: γ-glutamyl transpeptidase; ASA: American Society of Anesthesiology; NS: Not significant.
Comorbidities of patients with acute cholangitis n (%)
| Comorbidity | 93 (91.2) | 71 (67.6) | < 0.05 |
| Hypertension | 80 (78.4) | 53 (50.5) | < 0.05 |
| Ischemic heart disease | 40 (39.2) | 18 (17.1) | < 0.05 |
| Chronic heart failure | 8 (7.8) | 6 (5.7) | NS |
| Arrhythmia | 17 (16.7) | 14 (13.3) | NS |
| Cerebrovascular disease | 30 (29.4) | 10 (9.5) | < 0.05 |
| Dementia | 23 (22.5) | 4 (3.8) | < 0.05 |
| Diabetes mellitus | 21 (20.6) | 19 (18.1) | NS |
| Chronic liver disease | 9 (8.8) | 8 (7.6) | NS |
| Liver cirrhosis | 3 (2.9) | 3 (2.9) | NS |
| COPD/Asthma | 15 (14.7) | 7 (6.7) | < 0.05 |
| Chronic renal failure | 5 (4.9) | 4 (3.8) | NS |
| Malignancy | 8 (7.8) | 3 (2.9) | < 0.05 |
| Periampullary diverticulum | 25 (24.5) | 14 (13.3) | < 0.05 |
Malignancy other than a primary biliary and pancreatic lesion. COPD: Chronic obstructive pulmonary disease; NS: Not significant.
Etiology of acute cholangitis n (%)
| CBD stone | 65 (63.7) | 72 (68.6) | NS |
| Gallstone cholecystitis | 2 (2.0) | 4 (3.8) | NS |
| Pancreatitis | 1 (1.0) | 2 (1.9) | NS |
| Malignant obstruction | 31 (30.4) | 23 (21.9) | < 0.05 |
| Pancreatic cancer | 4 (3.9) | 5 (4.8) | NS |
| Biliary cancer | 21 (20.6) | 11 (10.5) | < 0.05 |
| GB cancer | 3 (2.9) | 4 (3.8) | NS |
| Other cause | 3 (2.9) | 3 (2.9) | NS |
| Benign stricture | 3 (2.9) | 4 (3.8) | NS |
Biliary obstruction caused by metastatic lymph node(s). CBD: Common bile duct; GB: Gall bladder; NS: Not significant.
Procedural details of endoscopic retrograde cholangiopancreatography n (%)
| Details of the procedure | |||
| Biliary stent insertion | 97 (95.1) | 100 (95.2) | NS |
| Endoscopic sphincterotomy | 69 (67.6) | 87 (82.9) | < 0.05 |
| Complete stone removal | 53/651 (81.5) | 67/722 (93.1) | < 0.05 |
| Technical success | 97 (95.1) | 100 (95.2) | NS |
| Procedures time (min), mean ± SD | 37.6 ± 8.1 | 40.1 ± 7.7 | NS |
| Failed cannulation | 5 (4.9) | 5 (4.8) | NS |
Number of patients with biliary stones in the elderly1 and in the control2 groups,
technical success is defined as an endoscopic biliary drainage at an initial ERCP. ERCP: Endoscopic retrograde cholangiopancreatography; NS: Not significant.
Endoscopic retrograde cholangiopancreatography-related complications n (%)
| Total | 7 (6.9) | 7 (6.7) | NS |
| Bleeding after EST | 3 (2.9) | 2 (1.9) | NS |
| Post-ERCP pancreatitis | 1 (1.0) | 4 (3.8) | < 0.05 |
| Aggravation of cholangitis | 2 (2.0) | 1 (1.0) | NS |
| Aspiration pneumonia | 1 (1.0) | 1 (1.0) | NS |
| Mortality | 0 | 0 | NA |
ERCP: Endoscopic retrograde cholangiopancreatography; EST: Endoscopic sphincterotomy; NS: Not significant; NA: Not available.
Cardiorespiratory suppression during endoscopic retrograde cholangiopancreatography under moderate sedation n (%)
| Total | 9 (8.8) | 8 (7.6) | NS |
| Hypoxemia | 2 (2.0) | 2 (1.9) | NS |
| Bradycardia | 4 (3.9) | 4 (3.8) | NS |
| Hypotension | 5 (4.9) | 4 (3.8) | NS |
Hypoxemia: Peripheral oxygen saturation (SpO2) below 90%; Bradycardia: Heart rate less than 45 beats per minutes; Hypotension: Systolic blood pressure below 80 mmHg; ERCP: Endoscopic retrograde cholangiopancreatography; NS: Not significant.